+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Implantable Pulse Generator Market - Forecasts from 2019 to 2024

  • ID: 4858219
  • Report
  • 113 pages
  • Knowledge Sourcing Intelligence LLP
1 of 3

FEATURED COMPANIES

  • Abbott
  • Cyberonics, Inc.
  • Dextronix, Inc.
  • Medtronic, Inc.
  • NeuroSigma, Inc.
  • Nevro Corp
  • MORE
Implantable pulse generator market is projected to grow at a CAGR of 9.86% during the forecast period, reaching a total market size of US$4.167 billion in 2024 from US$2.370 billion in 2018. An Implantable pulse generator is a battery-powered micro-electronic device, implanted in the body, which delivers electrical stimulation to the nervous system. Increasing prevalence of diseases and growing demand for innovative alternate therapies are the key driving factors that are boosting the demand for the implantable pulse generators. Other significant drivers fueling the increasing penetration of implantable pulse generators include ease of implants with enhanced clinical performance, good reimbursements, greater patient awareness, and advancing technology. The market is expected to grow at a steady pace owing to its increasing use to treat a wide array of medical conditions and diseases. Geographically, the implantable pulse generator is segmented as North America, Europe, Middle East & Africa, Asia-Pacific, and South America. North America holds a significant market share owing to the favorable reimbursement policies and sophisticated health infrastructure. The Asia Pacific is expected to grow at a significant rate owing to the advancing healthcare infrastructure and decreasing prices for implants in this region.

The “Implantable Pulse Generator Market - Forecasts from 2019 to 2024” is an exhaustive study that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by product type, application, end-user, and geography.

The implantable pulse generator market segmented based on product type, application, end-user, and geography. By product type, the market has been segmented into an implantable cardiac pacemaker, implantable spinal cord stimulator, implantable defibrillator, and others. By application, the market has been segmented into cardiovascular diseases, neurovascular diseases, and orthopedic. By end-user, the market has been segmented into hospitals and clinics, ambulatory surgical centers, and home care settings

Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa, and Asia Pacific regions. The report also analyzes 15 countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.

Major players in the Implantable Pulse Generator market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the implantable pulse generator market.

Segmentation:

By Product Type
  • Implantable Cardiac Pacemaker
  • Implantable Spinal Cord Stimulator
  • Implantable Defibrillator
  • Others
By Application
  • Cardiovascular Diseases
  • Neurovascular Diseases
  • Orthopedic
By End-User
  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Homecare Settings
By Geography

North America
USA
Canada
Mexico
  • South America
Brazil
Argentina
Others
  • Europe
Germany
France
United Kingdom
Spain
Others
  • Middle East and Africa
Israel
Saudi Arabia
Others
  • Asia Pacific
China
Japan
South Korea
India
Others
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott
  • Cyberonics, Inc.
  • Dextronix, Inc.
  • Medtronic, Inc.
  • NeuroSigma, Inc.
  • Nevro Corp
  • MORE
1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter's Five Force Analysis
4.5.1 Bargaining Power of Suppliers
4.5.2 Bargaining Power of Buyers
4.5.3 Threat of New Entrants
4.5.4 Threat of Substitutes
4.5.5 Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness

5. IMPLANTABLE PULSE GENERATOR MARKET BY PRODUCT TYPE
5.1. Implantable Cardiac Pacemaker
5.2. Implantable Spinal Cord Stimulator
5.3. Implantable Defibrillator
5.4. Others

6. IMPLANTABLE PULSE GENERATOR MARKET BY APPLICATION
6.1. Cardiovascular Diseases
6.2. Neurovascular Diseases
6.3. Orthopedic

7. IMPLANTABLE PULSE GENERATOR MARKET BY END-USER
7.1. Hospitals and Clinics
7.2. Ambulatory Surgical Centers
7.3. Homecare Settings

8. IMPLANTABLE PULSE GENERATOR MARKET BY GEOGRAPHY
8.1. North America
8.1.1. USA
8.1.2. Canada
8.1.3. Mexico
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. United Kingdom
8.3.4. Spain
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Israel
8.4.2. Saudi Arabia
8.4.3. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. Japan
8.5.3. South Korea
8.5.4. India
8.5.5. Others

9. COMPETITIVE INTELLIGENCE
9.1. Competitive Benchmarking and Analysis
9.2. Recent Investment and Deals
9.3. Strategies of Key Players

10. COMPANY PROFILES
10.1. Medtronic, Inc.
10.2. Abbott
10.3. Dextronix, Inc.
10.4. Nevro Corp
10.5. Integer Holdings Corporation
10.6. Boston Scientific Corporation
10.7. NeuroSigma, Inc.
10.8. Cyberonics, Inc.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Medtronic, Inc.
  • Abbott
  • Dextronix, Inc.
  • Nevro Corp
  • Integer Holdings Corporation
  • Boston Scientific Corporation
  • NeuroSigma, Inc.
  • Cyberonics, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll